Seven Leaf Competitors

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

Canopy is a world leading cannabis company focused on unleashing the power of cannabis to improve lives. From supporting personal wellness to fostering economic opportunity and striving towards social justice, Canopy is showcasing the capacity of cannabis as a force for good.

Organigram is a global cannabis company with deep roots in Canada, a strong presence in Germany through Sanity Group, and a growing footprint in key markets around the world. Publicly traded on the TSX and NASDAQ as OGI, we are focused on shaping the future of cannabis through science, innovation, strong brands and disciplined international growth. Canada is where our story began. Founded in 2013 and headquartered in Toronto, Organigram is now one of the country’s leading licensed producers, with cultivation, extraction, edibles and ready-to-consume facilities in Moncton, New Brunswick; Lac-Supérieur, Quebec; Winnipeg, Manitoba; Aylmer, Ontario; and London, Ontario. Our seed-to-shelf model gives us control over quality, consistency and innovation at every stage. It also supports a portfolio of brands that Canadians know and love, including SHRED, BOXHOT, Collective Project, Big Bag O’Buds, monjour, Wola and Tremblant. Internationally, we have a meaningful platform for growth. Through Sanity Group, one of Europe’s most prominent cannabis companies, we have a strong position in Germany, one of the world’s largest federally legal cannabis markets, and a foundation to grow across Europe. We also have a growing presence in the U.S. and Australia, extending our reach into key global markets. Innovation is what connects it all. From our Product Development Centre in Moncton, built with strategic investor British American Tobacco, to our patent-pending FAST™ nanoemulsion technology, we are continuing to advance cannabinoid science and raise the bar for cannabis products. At Organigram, we are working toward a more cannabis-friendly future, one where cannabis is better understood, more accessible and embraced as a mainstream choice. That responsibility extends beyond our products. Through our Operating for Good commitments, we invest in the communities where we live and work. Explore careers and learn more at organigram.ca/careers